These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 22785339)

  • 1. How to use ezetimibe as an anti-atherogenic agent via inhibition of Rho-kinase.
    Noma K; Higashi Y
    Circ J; 2012; 76(8):1836-7. PubMed ID: 22785339
    [No Abstract]   [Full Text] [Related]  

  • 2. Ezetimibe improves endothelial function and inhibits Rho-kinase activity associated with inhibition of cholesterol absorption in humans.
    Nochioka K; Tanaka S; Miura M; Zhulanqiqige do E; Fukumoto Y; Shiba N; Shimokawa H
    Circ J; 2012; 76(8):2023-30. PubMed ID: 22640986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letter by Westerink and Visseren regarding article, "Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation".
    Westerink J; Visseren FL
    Circulation; 2009 Sep; 120(9):e66; author reply e69-70. PubMed ID: 19720942
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter by Settergren et al regarding article, "Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation".
    Settergren M; Rydén L; Pernow J
    Circulation; 2009 Sep; 120(9):e68; author reply e69-70. PubMed ID: 19720944
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter by Tershakovec et al regarding article, "Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation".
    Tershakovec AM; Veltri EP; Pasternak RC
    Circulation; 2009 Sep; 120(9):e67; author reply e69-70. PubMed ID: 19720943
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of intestinal cholesterol absorption by ezetimibe is a novel therapeutic target for fatty liver.
    Yamagishi S; Nakamura K; Matsui T; Sato T; Takeuchi M
    Med Hypotheses; 2006; 66(4):844-6. PubMed ID: 16188393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition of the cholesterol absorption inhibitor ezetimibe in mdr1a/b (-/-) mice.
    Oswald S; Koll C; Siegmund W
    J Pharm Sci; 2007 Dec; 96(12):3478-84. PubMed ID: 17828742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-induced hypercholesterolemia in the rat relates to reduced elimination but not increased intestinal absorption of cholesterol.
    Gälman C; Matasconi M; Persson L; Parini P; Angelin B; Rudling M
    Am J Physiol Endocrinol Metab; 2007 Sep; 293(3):E737-42. PubMed ID: 17578886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell receptors regulate cholesterol : ezetimibe blocks cholesterol absorption.
    Cardiovasc J S Afr; 2006; 17(2):101. PubMed ID: 16733609
    [No Abstract]   [Full Text] [Related]  

  • 10. Ezetimibe (Schering-Plough).
    Meng CQ
    Curr Opin Investig Drugs; 2001 Mar; 2(3):389-92. PubMed ID: 11575710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An inhibitor of intestinal cholesterol transporter].
    Sano M
    Nihon Rinsho; 2013 Sep; 71(9):1661-6. PubMed ID: 24205731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SREBP-1c gene polymorphism is associated with increased inhibition of cholesterol-absorption in response to ezetimibe treatment.
    Berthold HK; Laaksonen R; Lehtimäki T; Gylling H; Krone W; Gouni-Berthold I
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):262-7. PubMed ID: 18072016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of intestinal cholesterol absorption by ezetimibe in humans.
    Sudhop T; Lütjohann D; Kodal A; Igel M; Tribble DL; Shah S; Perevozskaya I; von Bergmann K
    Circulation; 2002 Oct; 106(15):1943-8. PubMed ID: 12370217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in action of atorvastatin and ezetimibe in lowering low-density lipoprotein cholesterol and effect on endothelial function: randomized controlled trial.
    Matsue Y; Matsumura A; Suzuki M; Hashimoto Y; Yoshida M
    Circ J; 2013; 77(7):1791-8. PubMed ID: 23603824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption.
    Bruckert E; Giral P; Tellier P
    Circulation; 2003 Jul; 107(25):3124-8. PubMed ID: 12835406
    [No Abstract]   [Full Text] [Related]  

  • 16. Disposition and sterol-lowering effect of ezetimibe are influenced by single-dose coadministration of rifampin, an inhibitor of multidrug transport proteins.
    Oswald S; Giessmann T; Luetjohann D; Wegner D; Rosskopf D; Weitschies W; Siegmund W
    Clin Pharmacol Ther; 2006 Nov; 80(5):477-85. PubMed ID: 17112804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans.
    Davidson MH; Voogt J; Luchoomun J; Decaris J; Killion S; Boban D; Glass A; Mohammad H; Lu Y; Villegas D; Neese R; Hellerstein M; Neff D; Musliner T; Tomassini JE; Turner S
    Atherosclerosis; 2013 Oct; 230(2):322-9. PubMed ID: 24075764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Where does the interplay between cholesterol absorption and synthesis in the context of statin and/or ezetimibe treatment stand today?
    Descamps OS; De Sutter J; Guillaume M; Missault L
    Atherosclerosis; 2011 Aug; 217(2):308-21. PubMed ID: 21762916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cholesterol absorption inhibitor ezetimibe acts by blocking the sterol-induced internalization of NPC1L1.
    Ge L; Wang J; Qi W; Miao HH; Cao J; Qu YX; Li BL; Song BL
    Cell Metab; 2008 Jun; 7(6):508-19. PubMed ID: 18522832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Statins plus cholesterol resorption inhibitor. LDL goal values attainable].
    MMW Fortschr Med; 2002 Sep; 144(38):56. PubMed ID: 12395708
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.